Donna E. Hogge

14.6k citations

251 papers · 12.0k · 2 hit papers · h-index 59

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 174
- Acute Myeloid Leukemia Research 116
- Hematopoietic Stem Cell Transplantation 65
- Chronic Myeloid Leukemia Treatments 42
Genetics 46
- Chronic Lymphocytic Leukemia Research 26
- Virus-based gene therapy research 25

Co-authors: R. Keith Humphries (25 shared papers)Connie J. Eaves (24 shared papers)CJ Eaves (11 shared papers)Brigitte Gerhard (11 shared papers)PM Lansdorp (13 shared papers)Herbert J. Sutherland (16 shared papers)Allison Blair (4 shared papers)HJ Sutherland (9 shared papers)
Journals: Blood (75 papers)Transplantation and Cellular Therapy (18 papers)Bone Marrow Transplantation (13 papers)British Journal of Haematology (11 papers)Experimental Hematology (11 papers)
Partner nations: Canada United States Italy

In The Last Decade

Donna E. Hogge

248 papers receiving 11.6k citations

Donna E. Hogge's Hit Papers

align trajectories log scale

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial 2019 · 382 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2019 The Lancet Oncology
2018 Journal of Clinical Oncology

Peers

Countries citing papers authored by Donna E. Hogge

Since Specialization

Citations

This map shows the geographic impact of Donna E. Hogge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna E. Hogge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna E. Hogge more than expected).

Fields of papers citing papers by Donna E. Hogge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna E. Hogge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna E. Hogge. The network helps show where Donna E. Hogge may publish in the future.

Co-authors

The 25 scholars most cited alongside Donna E. Hogge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donna E. Hogge Line = papers co-authored together Donna E. Hogge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia Journal of Clinical Oncology ·Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes, Laura F. Newell, Tara L. Lin, Ellen Kelly Ritchie, Robert Kenneth Stuart, Stephen Anthony Strickland Hit paper breakdown →	2018	791
2	Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype Nature Medicine ·Daniel T. Starczynowski, Florian C. Kuchenbauer, Bob Argiropoulos, Sandy Sung, Ryan D. Morin, Andrew Muranyi, Martin Hirst, Donna E. Hogge	2009	561
3	Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proceedings of the National Academy of Sciences ·Guy Sauvageau, Peter M. Lansdorp, Connie J. Eaves, Donna E. Hogge, Wieslawa H. Dragowska, D S Reid, Corey Largman, H. Jeffrey Lawrence	1994	437
4	Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial The Lancet Oncology ·Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli, Alexander E. Perl, Siddhartha Ganguly, Nigel H. Russell, Alwin Krämer, Hervé Dombret Hit paper breakdown →	2019	382
5	Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proceedings of the National Academy of Sciences ·Andreas Leo Petzer, Donna E. Hogge, Peter M. Landsdorp, D S Reid, Connie J. Eaves	1996	338
6	Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML Blood ·Jeffrey E. Lancet, Jörge E. Cortes, Donna E. Hogge, Martin S. Tallman, Tibor J. Kovacsovics, Lloyd Earl Damon, Rami S. Komrokji, Scott R. Solomon	2014	298
7	Lack of Expression of Thy-1 (CD90) on Acute Myeloid Leukemia Cells With Long-Term Proliferative Ability In Vitro and In Vivo Blood ·Allison Blair, Donna E. Hogge, Laurie Ailles, Peter M. Lansdorp, Herbert J. Sutherland	1997	278
8	Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer Blood ·CJ Eaves, JD Cashman, R Kay, G J Dougherty, T Otsuka, LA Gaboury, Donna E. Hogge, PM Lansdorp	1991	270
9	Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML) Blood ·Yinghui Guan, Brigitte Gerhard, Donna E. Hogge	2003	228
10	Differential regulation of primitive human hematopoietic cells in long- term cultures maintained on genetically engineered murine stromal cells Blood ·HJ Sutherland, CJ Eaves, PM Lansdorp, JD Thacker, Donna E. Hogge	1991	217
11	Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor Blood ·Donna E. Hogge, PM Lansdorp, D S Reid, B. Gerhard, CJ Eaves	1996	212
12	Most Acute Myeloid Leukemia Progenitor Cells With Long-Term Proliferative Ability In Vitro and In Vivo Have the Phenotype CD34+/CD71−/HLA-DR− Blood ·Allison Blair, Donna E. Hogge, Herbert J. Sutherland	1998	202
13	Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells Leukemia ·Hiroyuki Kawagoe, R. Keith Humphries, Allison Blair, HJ Sutherland, Donna E. Hogge	1999	185
14	CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial The Lancet Haematology ·Jeffrey E. Lancet, Geoffrey L. Uy, Laura F. Newell, Tara L. Lin, Ellen Kelly Ritchie, Robert Kenneth Stuart, Stephen Anthony Strickland, Donna E. Hogge	2021	164
15	Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia Proceedings of the National Academy of Sciences ·Rodrigo T. Calado, Joshua A. Regal, Mark Hills, William T. Yewdell, Leandro Felipe Figueiredo Dalmazzo, Marco Antonio Zago, Peter M. Lansdorp, Donna E. Hogge	2009	156
16	Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML Cancer ·Jörge E. Cortes, Stuart L. Goldberg, Eric Jay Feldman, David Rizzeri, Donna E. Hogge, Melissa L. Larson, Arnaud Pigneux, Christian Récher	2014	154
17	Characterization of primitive hematopoietic cells in normal human peripheral blood Blood ·C Udomsakdi, PM Lansdorp, Donna E. Hogge, D S Reid, AC Eaves, CJ Eaves	1992	146
18	Interleukin-7 is a growth factor for Sézary lymphoma cells. Journal of Clinical Investigation ·AH Dalloul, Liliane Laroche, Martine Bagot, M. Djavad Mossalayi, C. R. Fourcade, D J Thacker, Donna E. Hogge, Hélène Merle‐Béral	1992	145
19	Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation Blood ·Thomas J. Nevill, Henry C.H. Fung, John D. Shepherd, Douglas E. Horsman, Stephen H. Nantel, Hans-G. Klingemann, Donna L. Forrest, Cynthia L. Toze	1998	140
20	Growth Characteristics of Acute Myelogenous Leukemia Progenitors That Initiate Malignant Hematopoiesis in Nonobese Diabetic/Severe Combined Immunodeficient Mice Blood ·Laurie Ailles, Brigitte Gerhard, Hiroyuki Kawagoe, Donna E. Hogge	1999	140

About Donna E. Hogge

Donna E. Hogge is a scholar working on Hematology, Genetics, Oncology, Immunology and Pathology and Forensic Medicine, having authored 251 papers that have together received 12.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (116 papers), Hematopoietic Stem Cell Transplantation (65 papers), Chronic Myeloid Leukemia Treatments (42 papers), Acute Lymphoblastic Leukemia research (32 papers), Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (26 papers), Virus-based gene therapy research (25 papers) and CAR-T cell therapy research (22 papers). The work is most often cited by research in Hematology (6.6k citations), Genetics (2.1k citations), Immunology (2.3k citations), Oncology (2.7k citations) and Molecular Biology (4.0k citations). Donna E. Hogge has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include R. Keith Humphries, Connie J. Eaves, CJ Eaves, Brigitte Gerhard, PM Lansdorp, Herbert J. Sutherland, Allison Blair, HJ Sutherland, Laurie Ailles and Michaela Feuring‐Buske. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Bone Marrow Transplantation, British Journal of Haematology and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Donna E. Hogge

Impact in

Papers in i

In The Last Decade

Donna E. Hogge

Donna E. Hogge's Hit Papers

Peers

Countries citing papers authored by Donna E. Hogge

Fields of papers citing papers by Donna E. Hogge

All Works

About Donna E. Hogge

Explore authors with similar magnitude of impact

Papers in